Clinical Trials Browser

Interventional × Ursodeoxycholic Acid × Gastrointestinal × Clear all

NCT00873275 2025-06-22

Ursodiol, Combination Chemotherapy, and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer

Phase 1 Completed

11 enrolled

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT01505569 2024-02-26

Auto Transplant for High Risk or Relapsed Solid or CNS Tumors

Phase NA Completed

44 enrolled

CNSGastrointestinalGenitourinaryOther solid neoplasmSarcoma

Brain Neoplasms, Carcinoma, Renal Cell, Medulloblastoma, Neoplasms, Germ Cell and Embryonal, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Central Nervous System Neoplasms, Hepatoblastoma, Rhabdoid Tumor

NCT01097304 2017-12-19

Ursodiol in Treating Patients With Barrett Esophagus and Low-Grade Dysplasia

Phase 2 Completed

36 enrolled 10 charts

Gastrointestinal

Barrett Esophagus, Esophageal Neoplasms

NCT01149304 2017-11-20

ELDORADO

Phase 2 Completed

22 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT00808743 2013-05-16

PreDuoFAP

Phase 2/3 Completed

37 enrolled

Gastrointestinal

Adenoma, Digestive System Diseases, Digestive System Neoplasms, Duodenal Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Neoplastic Syndromes, Hereditary, Adenomatous Polyposis Coli, Polyps, Adenomatous Polyps, Genetic Diseases, Inborn

NCT00062023 2012-07-30

Comparison of Sulindac, Aspirin, and Ursodiol in Preventing Colorectal Cancer

Phase 2 Terminated

12 enrolled

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT00134758 2009-07-29

Ursodeoxycholic Acid in the Treatment of Duodenal Adenomas in Familial Adenomatous Polyposis (FAP) Patients

Phase 2/3 Unknown

90 enrolled

Gastrointestinal

Adenoma, Adenomatous Polyposis Coli